Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,198 | 183,452 | 197,672 | -2,964 | 4,639 |
| Depreciation Amortization | -176 | 676 | 741 | 547 | 326 |
| Accounts receivable | -4,824 | -2,543 | -2,449 | -3,001 | -3,160 |
| Accounts payable and accrued liabilities | 1,349 | -27,654 | -26,306 | -21,692 | -24,766 |
| Other Working Capital | 270 | -153,032 | -148,190 | 12,139 | -5,652 |
| Other Operating Activity | 4,692 | -5,673 | -7,914 | 30,372 | 31,332 |
| Operating Cash Flow | $-13,887 | $-4,774 | $13,554 | $15,401 | $2,719 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -11,055 | -61,158 | -3,035 | N/A | N/A |
| PPE Investments | N/A | -38 | -38 | -29 | -16 |
| Net Acquisitions | -60 | 96,615 | 90,204 | N/A | N/A |
| Sale Of Investment | 14,133 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $3,018 | $35,419 | $87,131 | $-29 | $-16 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -80,560 | -80,554 | -2 | -5 |
| Other Financing Activity | -7 | -5,468 | -5,460 | -95 | -83 |
| Financing Cash Flow | $-7 | $-86,028 | $-86,014 | $-97 | $-88 |
| Exchange Rate Effect | 1 | 1,077 | 1,126 | 2,388 | 1,407 |
| Beginning Cash Position | 47,872 | 102,178 | 102,178 | 102,178 | 102,178 |
| End Cash Position | 36,997 | 47,872 | 117,975 | 119,841 | 106,200 |
| Net Cash Flow | $-10,875 | $-54,306 | $15,797 | $17,663 | $4,022 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,887 | -4,774 | 13,554 | 15,401 | 2,719 |
| Capital Expenditure | N/A | -38 | -38 | -29 | -16 |
| Free Cash Flow | -13,887 | -4,812 | 13,516 | 15,372 | 2,703 |